Hyperliquid Strategies (NASDAQ:PURR) Stock Rating Upgraded by Wall Street Zen

Hyperliquid Strategies (NASDAQ:PURR) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a research report issued to clients and investors on Saturday.

Several other research analysts have also recently weighed in on PURR. Cantor Fitzgerald lifted their price target on shares of Hyperliquid Strategies from $5.00 to $6.00 and gave the stock an “overweight” rating in a research note on Thursday, February 12th. Chardan Capital lifted their target price on Hyperliquid Strategies from $8.15 to $8.45 and gave the company a “buy” rating in a research report on Thursday, February 12th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Hyperliquid Strategies currently has an average rating of “Buy” and a consensus target price of $7.23.

Hyperliquid Strategies Stock Up 6.7%

Hyperliquid Strategies stock opened at $4.29 on Friday. Hyperliquid Strategies has a 52-week low of $3.01 and a 52-week high of $5.78. The stock has a market cap of $531.83 million, a price-to-earnings ratio of -0.46 and a beta of 1.56.

Hyperliquid Strategies (NASDAQ:PURR) last issued its quarterly earnings data on Wednesday, February 11th. The company reported ($7.43) earnings per share for the quarter. The firm had revenue of $0.50 million for the quarter.

Institutional Investors Weigh In On Hyperliquid Strategies

A number of institutional investors have recently added to or reduced their stakes in the stock. Boothbay Fund Management LLC purchased a new position in shares of Hyperliquid Strategies in the fourth quarter worth $40,000. XTX Topco Ltd bought a new stake in Hyperliquid Strategies in the 4th quarter valued at $48,000. Squarepoint Ops LLC purchased a new stake in Hyperliquid Strategies in the 4th quarter worth $73,000. Millennium Management LLC purchased a new stake in Hyperliquid Strategies in the 4th quarter worth $87,000. Finally, Ikarian Capital LLC bought a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $107,000. 9.45% of the stock is owned by hedge funds and other institutional investors.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.